Japanese encephalitis virus envelope proteins — Drug Target
All drugs that target Japanese encephalitis virus envelope proteins — marketed and clinical-stage. Includes 3 drug classes acting on this target.
Drug classes
vaccine · Vaccine · Live attenuated vaccine
Marketed (3)
- JE vaccine new plant lot 2 · International Centre for Diarrhoeal Disease Research, Bangladesh · vaccine · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JE Vaccine existing facility · International Centre for Diarrhoeal Disease Research, Bangladesh · Vaccine · Infectious Disease / Immunology
JE Vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JE vaccine new plant lot 1 · International Centre for Diarrhoeal Disease Research, Bangladesh · vaccine · Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus.
Phase 3 pipeline (2)
- JE vaccine · Boryung Pharmaceutical Co., Ltd · Vaccine · Infectious Disease / Immunology
JE vaccine stimulates the immune system to produce antibodies and cellular immunity against Japanese encephalitis virus. - JECEVAX · National Institute of Hygiene and Epidemiology, Vietnam · Live attenuated vaccine · Immunology / Infectious Disease
JECEVAX is a live attenuated Japanese encephalitis vaccine that stimulates immune responses against Japanese encephalitis virus.